Endocrinology Practice Questions

Q: Which of the following statements regarding growth hormone is incorrect?

It lowers blood sugar levels if present in excess.. **Explanation:** **1. Why Option A is the correct (incorrect statement):** Growth Hormone (GH) is a **diabetogenic hormone**. It does not lower blood sugar; instead, it increases it. GH antagonizes the action of insulin, decreases glucose uptake by peripheral tissues (like muscle and adipose tissue), and increases hepatic glucose production (gluconeogenesis). Chronic excess of GH, as seen in acromegaly, can lead to "pituitary diabetes." **2. Analysis of other options:** * **Option B:** GH is strongly **anabolic**. It promotes amino acid uptake and protein synthesis in muscles and organs, leading to a positive nitrogen balance. * **Option C:** In healthy individuals, dopamine stimulates GH release. However, in patients with GH-secreting **pituitary adenomas** (Acromegaly), dopaminergic agonists (like Bromocriptine or Cabergoline) paradoxically **suppress** GH secretion. This is a classic high-yield physiological shift used in medical management. * **Option D:** While GH has some direct effects (like lipolysis), most of its growth-promoting actions (skeletal and cartilage growth) are mediated by **IGF-1 (Somatomedin C)**, which is primarily produced in the liver. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolic effects:** GH is Lipolytic (increases FFA), Diabetogenic (hyperglycemic), and Anabolic (protein sparer). * **Stimulators of GH:** Hypoglycemia, fasting, sleep (Stage 3 & 4), exercise, and Arginine. * **Inhibitors of GH:** Hyperglycemia, Somatostatin, and IGF-1 (via negative feedback). * **Diagnosis:** The gold standard for diagnosing Acromegaly is the failure to suppress GH levels below 1 ng/mL following an **Oral Glucose Tolerance Test (OGTT)**.

Q: C-peptide is secreted by which type of pancreatic islet cell?

Beta cells. **Explanation:** **Why Beta cells are correct:** C-peptide (Connecting peptide) is a byproduct of insulin synthesis within the **Beta cells** of the Islets of Langerhans. Insulin is initially synthesized as a precursor molecule called **Preproinsulin**, which is cleaved into **Proinsulin**. In the Golgi apparatus, proinsulin is packaged into secretory granules where it is cleaved by endopeptidases into equal amounts (equimolar concentrations) of **Insulin** and **C-peptide**. Both are then released into the portal circulation via exocytosis. **Why other options are incorrect:** * **Alpha cells:** These cells secrete **Glucagon**, which increases blood glucose levels by stimulating glycogenolysis and gluconeogenesis. * **Delta cells:** These cells secrete **Somatostatin**, which acts as a universal inhibitor, suppressing the release of both insulin and glucagon. * **F cells (PP cells):** These cells secrete **Pancreatic Polypeptide**, which helps regulate pancreatic exocrine secretions and gallbladder contraction. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Utility:** Since C-peptide is secreted in a **1:1 ratio** with endogenous insulin but has a longer half-life (~30 mins vs. ~5 mins for insulin), it serves as a reliable marker of endogenous Beta-cell function. * **Factitious Hypoglycemia:** In cases of exogenous insulin overdose, C-peptide levels will be **low** (because commercial insulin lacks C-peptide). In contrast, in an **Insulinoma**, both insulin and C-peptide levels will be **elevated**. * **Metabolism:** Unlike insulin, which is primarily cleared by the liver, C-peptide is mainly cleared by the **kidneys**.

Q: Which of the following suppresses the activity of osteoblasts?

Corticosterone. **Explanation:** The correct answer is **Corticosterone** (a glucocorticoid). Glucocorticoids are potent inhibitors of bone formation. They suppress osteoblast activity through several mechanisms: they decrease the proliferation and differentiation of osteoblast precursors, increase the apoptosis of mature osteoblasts and osteocytes, and shift the differentiation of mesenchymal stem cells away from the osteoblast lineage toward adipocytes. **Analysis of Options:** * **A. Vitamin D3 (Calcitriol):** It primarily promotes bone mineralization by increasing intestinal calcium and phosphate absorption. It also stimulates osteoblasts to secrete proteins like osteocalcin and RANKL (which indirectly activates osteoclasts), but its net physiological role is essential for healthy bone formation. * **B. T3 and T4 (Thyroid Hormones):** These are essential for normal bone growth and skeletal maturation. They stimulate osteoblast activity and protein synthesis. While hyperthyroidism can lead to increased bone turnover, thyroid hormones do not "suppress" osteoblasts. * **D. Parathormone (PTH):** PTH has a dual effect. While continuous high levels stimulate osteoclasts (via RANKL from osteoblasts), intermittent low doses of PTH are actually **anabolic** to bone and stimulate osteoblast activity (the basis for the drug Teriparatide). **Clinical Pearls for NEET-PG:** * **Glucocorticoid-Induced Osteoporosis (GIOP):** This is the most common cause of secondary osteoporosis. The hallmark is a decrease in bone formation rather than just an increase in resorption. * **Osteoblast Markers:** High-yield markers for osteoblast activity include **Alkaline Phosphatase (ALP)** and **Osteocalcin**. * **RANKL/OPG Ratio:** Osteoblasts regulate osteoclasts by secreting RANKL (stimulates osteoclasts) and Osteoprotegerin (OPG, inhibits osteoclasts). Glucocorticoids increase RANKL and decrease OPG, further damaging bone integrity.

Q: A hormone acts to stimulate its neighbouring cell to divide. To which category of signaling does this hormone's action best belong?

Paracrine signaling. **Explanation:** The correct answer is **Paracrine signaling**. This mode of communication involves a cell secreting a chemical messenger (hormone or cytokine) that diffuses through the interstitial fluid to act on **neighboring or adjacent cells** of a different type. Since the question specifies the hormone acts on its "neighboring cell," it perfectly fits the definition of paracrine action. **Analysis of Options:** * **Autocrine signaling:** In this mechanism, the hormone or chemical messenger acts on the **same cell** that secreted it (self-stimulation). This is common in cancer cell proliferation and immune responses (e.g., Interleukin-2 acting on the same T-cell). * **Endocrine signaling:** This involves hormones being secreted into the **bloodstream** to act on distant target organs. This is the classic mechanism for hormones like Insulin or Thyroxine. * **Juxtacrine signaling (Related Concept):** This requires direct physical contact between the membranes of two cells (e.g., Notch signaling). **High-Yield NEET-PG Pearls:** * **Paracrine Example:** Somatostatin secreted by Delta cells of the Islets of Langerhans inhibits the secretion of Insulin (Beta cells) and Glucagon (Alpha cells) in its immediate vicinity. * **Neuroendocrine:** A variation where a neuron releases a hormone into the blood (e.g., ADH from the posterior pituitary). * **Intracrine:** A hormone acts inside the cell without ever being secreted (e.g., Steroid hormones acting on nuclear receptors). * **Key Distinction:** The primary difference between these signaling types is the **distance** the messenger travels and the **medium** (interstitial fluid vs. blood) it uses.

Q: Which hormone stimulates the production of IGF?

GH. **Explanation:** **1. Why GH is the correct answer:** Growth Hormone (GH), secreted by the somatotrophs of the anterior pituitary, does not exert most of its growth-promoting effects directly. Instead, it acts primarily by stimulating the liver (and to a lesser extent, skeletal muscle and cartilage) to produce **Insulin-like Growth Factor-1 (IGF-1)**, also known as **Somatomedin C**. The GH-IGF-1 axis is the primary pathway for longitudinal bone growth and protein synthesis. While GH has direct metabolic effects (lipolysis and anti-insulin actions), its anabolic and growth-promoting functions are mediated by IGF-1. **2. Why other options are incorrect:** * **LH (Luteinizing Hormone):** Stimulates Leydig cells in testes to produce testosterone and triggers ovulation/progesterone production in ovaries. * **PRL (Prolactin):** Primarily responsible for milk production (lactogenesis) and inhibiting GnRH; it has no significant role in IGF production. * **TSH (Thyroid Stimulating Hormone):** Stimulates the thyroid gland to synthesize and release T3 and T4, which regulate the basal metabolic rate. **3. NEET-PG High-Yield Pearls:** * **Site of Production:** The **liver** is the principal source of circulating IGF-1. * **Feedback Loop:** IGF-1 exerts negative feedback on the anterior pituitary to inhibit GH secretion and stimulates the hypothalamus to release Somatostatin (GHIH). * **Clinical Correlation:** In **Laron Dwarfism**, there is a genetic GH receptor deficiency; GH levels are high, but IGF-1 levels are low, and patients do not respond to exogenous GH. * **Diagnosis:** Serum IGF-1 levels are more stable than GH levels (which are pulsatile) and are used as the primary screening tool for **Acromegaly**.

Q: The hormone whose deficiency causes diabetes insipidus is released from which nucleus of the pituitary gland?

Supraoptic. The hormone whose deficiency causes **Diabetes Insipidus (DI)** is **Antidiuretic Hormone (ADH)**, also known as Vasopressin [1]. ADH is synthesized in the hypothalamus and transported to the posterior pituitary (neurohypophysis) for storage and release [2]. 1. **Why Option A is Correct:** While both the **Supraoptic** and **Paraventricular** nuclei synthesize ADH and Oxytocin, the **Supraoptic nucleus (SON)** is primarily responsible for the production of **ADH** (approx. 5:1 ratio) [1]. Damage to the SON or the hypothalamo-hypophyseal tract leads to Central Diabetes Insipidus, characterized by polyuria and polydipsia [1]. 2. **Why Other Options are Incorrect:** * **Paraventricular Nucleus (PVN):** Primarily responsible for the synthesis of **Oxytocin**. While it produces some ADH, it is not the predominant source [2]. * **Suprachiasmatic Nucleus:** This nucleus is the master pacemaker for **circadian rhythms** (biological clock), responding to light-dark cycles. * **Pre-optic Nucleus:** Involved in **thermoregulation** and the release of Gonadotropin-Releasing Hormone (GnRH). **High-Yield Clinical Pearls for NEET-PG:** * **Site of Synthesis vs. Release:** ADH is *synthesized* in the hypothalamus (SON) but *released* from the posterior pituitary (Pars Nervosa) [2]. * **Mechanism of Action:** ADH acts on **V2 receptors** in the late distal tubule and collecting ducts to insert **Aquaporin-2** channels, facilitating water reabsorption [3]. * **Diagnostic Test:** The **Water Deprivation Test** is used to differentiate between Central DI, Nephrogenic DI, and Primary Polydipsia [4]. * **Treatment:** Desmopressin (DDAVP) is the drug of choice for Central Diabetes Insipidus.

Q: Elevated levels of somatostatin are pathologically associated with which of the following blood hormone levels?

Low growth hormone (GH). **Explanation:** **1. Why the Correct Answer is Right:** Somatostatin, also known as **Growth Hormone Inhibiting Hormone (GHIH)**, is a potent inhibitory peptide produced primarily by the hypothalamus and the delta cells of the pancreas. Its primary physiological role in the anterior pituitary is to **inhibit the secretion of Growth Hormone (GH)**. Therefore, pathologically elevated levels of somatostatin (such as in a somatostatinoma) will lead to the suppression of GH release, resulting in **low GH levels**. **2. Why the Other Options are Incorrect:** * **High Prolactin (PRL):** Prolactin is primarily regulated by the inhibitory action of **Dopamine**. Somatostatin does not significantly regulate prolactin; thus, elevated somatostatin would not cause high PRL. * **High TSH:** Somatostatin actually **inhibits** the release of Thyroid Stimulating Hormone (TSH). Therefore, high somatostatin would lead to *low* TSH levels, not high. * **High Cortisol:** Cortisol is regulated by the ACTH axis. Somatostatin has no major inhibitory or stimulatory effect on the secretion of ACTH or cortisol under normal physiological conditions. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Dual Inhibition:** Somatostatin inhibits both **GH and TSH** from the anterior pituitary. * **Pancreatic Action:** In the pancreas, it acts paracrinely to inhibit both **Insulin and Glucagon** secretion. * **Gastrointestinal Action:** It decreases gastric acid secretion (inhibits Gastrin), gallbladder contraction (inhibits CCK), and pancreatic enzyme secretion. * **Clinical Use:** Synthetic analogs like **Octreotide** are used clinically to treat Acromegaly (by lowering GH), secretory diarrheas (Carcinoid syndrome), and esophageal varices. * **Somatostatinoma Triad:** Steatorrhea, Diabetes Mellitus, and Cholelithiasis (due to global inhibition of GI hormones).

Q: Estrogen receptors are present in which of the following bone cells?

All of the above. **Explanation:** Estrogen plays a pivotal role in maintaining bone mineral density and regulating bone remodeling. Traditionally, it was believed that estrogen acted primarily on osteoblasts; however, molecular research has confirmed that **Estrogen Receptors (ER-α and ER-β)** are expressed in **all major types of bone cells**, making "All of the above" the correct answer. **Mechanism of Action:** 1. **Osteoblasts:** Estrogen binds to receptors on osteoblasts to increase their proliferation and differentiation. It stimulates the production of **OPG (Osteoprotegerin)**, which acts as a decoy receptor for RANKL, thereby inhibiting osteoclastogenesis. 2. **Osteoclasts:** Estrogen acts directly on osteoclasts to induce **apoptosis** and decrease their resorptive activity. It also indirectly inhibits them by reducing the expression of RANKL by T-cells and osteoblasts. 3. **Osteocytes:** Estrogen receptors in osteocytes help prevent cell death (apoptosis). Since osteocytes sense mechanical strain, estrogen helps maintain the integrity of the bone matrix through these cells. **Why other options are incorrect:** Options A, B, and C are individual components of the bone remodeling unit. While estrogen does act on each, selecting only one would be incomplete. The integrated action across all three cell types is what ensures the "anti-resorptive" effect of estrogen. **High-Yield Clinical Pearls for NEET-PG:** * **Postmenopausal Osteoporosis:** The decline in estrogen leads to an increase in RANKL and a decrease in OPG, resulting in unchecked osteoclast activity and rapid bone loss. * **Cytokine Regulation:** Estrogen suppresses pro-inflammatory cytokines like **IL-1, IL-6, and TNF-α**, which are potent stimulators of bone resorption. * **Biochemical Marker:** In estrogen deficiency, there is an increase in bone turnover markers (e.g., urinary N-telopeptide).

Question 1

Which of the following statements regarding growth hormone is incorrect?

Accepted Answer

It lowers blood sugar levels if present in excess.

Answer

It has a strong anabolic action.

Answer

Dopaminergic agonists depress its release in pituitary adenomas.

Answer

Its action is mediated by IGF-1.

Question 2

C-peptide is secreted by which type of pancreatic islet cell?

Accepted Answer

Beta cells

Answer

Alpha cells

Answer

Delta cells

Answer

F cells

Question 3

Which of the following conditions increases aldosterone secretion without affecting glucocorticoid secretion?

Accepted Answer

All of the above

Answer

High potassium intake

Answer

Low sodium intake

Answer

Constriction of the inferior vena cava in the thorax

Question 4

Which of the following suppresses the activity of osteoblasts?

Accepted Answer

Corticosterone

Answer

Vitamin D3

Answer

T3 and T4

Answer

Parathormone

Question 5

A hormone acts to stimulate its neighbouring cell to divide. To which category of signaling does this hormone's action best belong?

Accepted Answer

Paracrine signaling

Answer

Autocrine signaling

Answer

Endocrine signaling

Answer

None of the above

Question 6

Which hormone stimulates the production of IGF?

Accepted Answer

GH

Answer

LH

Answer

PRL

Answer

TSH

Question 7

Which is the single most important factor that stimulates insulin secretion?

Accepted Answer

Increased plasma glucose concentration stimulates insulin release

Answer

Decreased plasma glucose concentration inhibits insulin release

Answer

Decreased plasma glucose concentration stimulates insulin release

Answer

Increased plasma glucose concentration inhibits insulin release

Question 8

The hormone whose deficiency causes diabetes insipidus is released from which nucleus of the pituitary gland?

Accepted Answer

Supraoptic

Answer

Pre optic

Answer

Suprachiasmatic

Answer

Paraventricular

Question 9

Elevated levels of somatostatin are pathologically associated with which of the following blood hormone levels?

Accepted Answer

Low growth hormone (GH)

Answer

High prolactin (PRL)

Answer

High TSH

Answer

High cortisol

Question 10

Estrogen receptors are present in which of the following bone cells?

Accepted Answer

All of the above

Answer

Osteoblasts

Answer

Osteoclasts

Answer

Osteocytes

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?